p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines

Cell Proliferation

Volumn 29, Issue 5, 1996, Pages 219-230

  Servomaa, K ^a   Kiuru, A ^a   Grenman R ^b   Pekkola Heino, K ^b   Pulkkinen, J O ^b   Rytomaa T ^a  

^a STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CLONOGENIC ASSAY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; POLYMERASE CHAIN REACTION; RADIATION DOSE; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

EID: 0029840251     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1996.01009.x     Document Type: Article

References (34)

1. AHOMADEGBE JC, BARROIS M, FOGEL S et al. (1995) High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10, 1217.
2. BIARD DSF, MARTIN M, LE RHUN Y et al. (1994) Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Research 54, 3361.
3. BRACHMAN DG, BECKETT M, GRAVES D, HARAF D, VOKES E, WEICHSELBAUM RR. (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research 53, 3667.
4. CAELLES C, HELMBERG A, KARIN M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220.
5. CLARKE AR, PURDIE CA, HARRISON DJ, MORRIS RG, BIRD CC, HOOPER ML, WYLLIE AH. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849.
6. FERTIL B, DETINGER H, COURDI A, MALAISE P. (1984) Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res. 99, 73.
7. GREENBLATT MS, BENNETT WP, HOLLSTEIN M. HARRIS CC. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54, 4855.
8. GRENMAN R, BURK D, VIROLAINEN E, WAGNER JG, LICHTER AS, CAREY TE. (1988) Radiosensitivity of head and neck cancer cells in vitro. Arch. Otolaryngol Head Neck Surg. 114, 427.
9. GRÉNMAN R, BURK D, VIROLAINEN E et al. (1989) Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int. J. Cancer 44, 131.
10. GRÉNMAN R, CAREY TE, MCCLATCHEY KD et al. (1991) In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67, 2741.
11. GRÉNMAN R, PEKKOLA-HEINO K, JOENSUU H, AITASALO K, KLEMI P, LAKKALA T. (1992) UT-MUC-1, a new mucoepidermoid carcinoma cell line and its radiosensitivity. Arch. Otolaryngol. Head Neck Surg. 118, 542.
12. HENDRY JH, POTTEN CS, MERRITT A. (1995) Apoptosis induced by high- and low-LET radiation. Radiat. Environ. Biophys. 34, 59.
13. HOLLSTEIN M, RICE K, GREENBLATT MS et al. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551.
14. JUNG M, NOTARIO V, DRITSCHILO A. (1992) Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Research 54, 6390.
15. KASTAN MB, ONYERKWERE O, SIDRANSKY D, VOGELSTEIN B, CRAIG RW. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51, 6304.
16. KASTAN MB, ZHAN Q, EL-DEIRY WS et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587.
17. KUERBITZ SJ, PLUNKETT BS, WALSH WV, KASTAN MB. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad Sci. USA 89, 7491.
18. LANE DP. (1992) p53, quardian of the genome. Nature 358, 15.
19. LANE DP. (1993) A death of the life of p53. Nature 362, 786.
20. LEE JM, BERNSTEIN A. (1993) p53 mutations increase resistance to ionizing radiation. Proc. Natl Acad. Sci. USA 90, 5742.
21. LEITH JT. (1994) Correpsondence re: D. G. Brachman et al. (1993). Mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research 53, 3667.
22. Cancer Resesarch 54, 5021.
23. LOWE SW, BODIS S, MCCLATCHEY A et al. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266, 807.
24. MCILWRATH AJ, VASEY PA, ROS GM, BROWN R. (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research 54, 3718.
25. MERRIT AJ, POTTEN CS, KEMP CJ et al. (1994) The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Research 54, 614.
26. O'REILLEY S, MOTHERSILL C, SEYMOUR CB. (1994) Postirradiation expression of lethal mutations in an immortalized human keratinocyte cell line. Int. J. Radiat. Biol. 66, 77.
27. PEKKOLA-HEINO K, JOENSUU H, KLEMI P, GRÉNMAN R. (1994) Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous cell carcinoma cell lines. Arch. Otolaryngol. Head Neck Surg. 120, 750.
28. PEKKOLA-HEINO K, KULMALA J, KLEMI P et al. (1991) Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J. Cancer Res. Clin. Oncol. 117, 597.
29. SERVOMAA K, LESZCZYNSKI D, LANG S, KOSMA V-M, RYTÖMAA T. (1994) Apparent radiation-specific point mutation in the tumour suppressor gene p53 in malignant lung tumours in rat. In: Chadwick KH, Cox R, Leenhouts HP, Thacker J, eds. Molecular Mechanisms in Radiation Mutagenesis and Carcinogenesis. Report EUR 15294, ECSC-EC-EAEC. Brussels: European Commission, 223.
30. SEYMOUR C, MOTHERSILL C. (1992) All colonies of CHO-K1 cells surviving gamma-irradiation contain non-viable cells. Mutat. Res. 267, 19.
31. SMITH ML, CHEN I-T, ZHAN Q, O'CONNOR PM, FORNACE AJ. (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10, 1053.
32. WATTEL E, PREUDHOMME C, HECQUET B et al. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84 3148.
33. XIA F, WANG X, WANG Y-H et al. (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Research 55, 12.
34. ZHAN Q, BAE U, KASTAN MB, FORNACE AJ. (1994) The p53-dependent γ-ray response of GADD45. Cancer Research 54, 2755.